Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Amylyx Pharmaceuticals, Inc. (AMLX)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 67,520,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Amylyx Pharmaceuticals is engaged in the development of therapies that change the treatment paradigm for amyotrophic lateral sclerosis, and a range of neurodegenerative diseases. Co. is pursuing commercialization of its product candidate, AMX0035, which is a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and tauroursodeoxycholic acid. Co. is also developing AMX0035 for other neurodegenerative diseases including Alzheimer's Disease, Wolfram syndrome, Parkinson's Disease, Huntington's Disease, Progressive Supranuclear Palsy, Multi-System Atrophy, primary lateral sclerosis, ischemic stroke, Friedreich's ataxia, Leigh's syndrome and Leber's hereditary optic neuropathy.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 4,000 4,000 5,000
Total Buy Value $0 $59,880 $59,880 $91,870
Total People Bought 0 1 1 1
Total Buy Transactions 0 1 1 2
Total Shares Sold 31,650 31,650 231,858 2,678,586
Total Sell Value $551,518 $551,518 $6,453,955 $81,903,056
Total People Sold 5 5 6 10
Total Sell Transactions 9 9 14 39
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 91
  Page 1 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Mazzariello Gina Chief Legal Officer   •       –      –    2024-03-05 4 S $18.73 $28,841 D/D (1,540) 81,372     -
   Frates James M Chief Financial Officer   •       –      –    2024-03-05 4 S $18.73 $33,560 D/D (1,792) 134,784     -
   Cohen Joshua B Co-Chief Executive Officer   •       •      –    2024-03-05 4 S $18.73 $77,440 D/D (4,135) 3,023,002     -
   Klee Justin B. Co-Chief Executive Officer   •       •      –    2024-03-05 4 S $18.73 $77,440 D/D (4,135) 2,959,308     -
   Mazzariello Gina Chief Legal Officer   •       –      –    2024-02-26 4 A $0.00 $0 D/D 36,667 82,912     -
   Frates James M Chief Financial Officer   •       –      –    2024-02-26 4 A $0.00 $0 D/D 40,000 152,035     -
   Cohen Joshua B Co-Chief Executive Officer   •       •      –    2024-02-26 4 A $0.00 $0 D/D 126,667 3,027,137     -
   Klee Justin B. Co-Chief Executive Officer   •       •      –    2024-02-26 4 A $0.00 $0 D/D 126,667 2,963,443     -
   Mazzariello Gina Chief Legal Officer   •       –      –    2024-02-23 4 S $18.76 $53,231 D/D (2,838) 46,245     -
   Milne George M Jr   –       •      –    2024-01-25 4 GD $0.00 $0 D/D 9,100 758,571     -
   Milne George M Jr   –       •      –    2024-01-16 4 GD $0.00 $0 D/D 94,350 767,671     -
   Cohen Joshua B Co-Chief Executive Officer   •       •      –    2024-01-09 4 S $16.33 $95,372 D/D (5,841) 2,900,470     -
   Yeramian Patrick D Chief Medical Officer   •       –      –    2024-01-09 4 S $16.33 $45,915 D/D (2,812) 205,605     -
   Frates James M Chief Financial Officer   •       –      –    2024-01-09 4 S $16.33 $44,347 D/D (2,716) 112,035     -
   Klee Justin B. Co-Chief Executive Officer   •       •      –    2024-01-09 4 S $16.33 $95,372 D/D (5,841) 2,836,776     -
   Olinger Margaret Chief Commercial Officer   •       –      –    2023-12-27 4 OE $0.37 $9,250 D/D 25,000 276,108     -
   Firestone Karen   –       •      –    2023-12-15 4 B $14.97 $59,880 D/D 4,000 5,000 0.01     -
   Bedrosian Camille L Chief Medical Officer   •       –      –    2023-11-27 4 A $0.00 $0 D/D 58,333 58,333     -
   Cohen Joshua B Co-Chief Executive Officer   •       •      –    2023-11-16 4 OE $1.57 $100,000 D/D 63,694 2,906,311     -
   Frates James M Chief Financial Officer   •       –      –    2023-10-31 4 GA $0.00 $0 I/I 11,072 11,072     -
   Frates James M Chief Financial Officer   •       –      –    2023-08-23 4 OE $6.88 $124,975 D/D 18,165 106,341     -
   Mazzariello Gina Chief Legal Officer   •       –      –    2023-08-15 4 AS $20.88 $128,686 D/D (6,164) 49,083     -
   Morningside Venture Investments Ltd 10% Owner   –       –       •   2023-08-15 4 GD $0.00 $0 D/D 2,000,000 4,997,302     -
   Olinger Margaret Chief Commercial Officer   •       –      –    2023-07-12 4 OE $0.37 $7,400 D/D 20,000 251,108     -
   Olinger Margaret Chief Commercial Officer   •       –      –    2023-05-22 4 GD $0.00 $0 D/D 1,580 231,108     -

  91 Records found
  1  2  3  4   
  Page 1 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed